Novel primary malignancies, tumor promotion in BRAF wild-type patients, hypersensitivity reactions, dermatologic reactions, QT prolongation, hepatotoxicity, photosensitivity, opthamologic reactions94–96. Here, BRAF is linked to neoplasm.